Monozygotic twins discordant for chronic fatigue syndrome: Regional cerebral blood flow SPECT

Radiology

Volumn 219, Issue 3, 2001, Pages 766-773

  Lewis, David H ^a   Mayberg, Helen S ^d   Fischer, Mary E ^c   Goldberg, Jack ^c   Ashton, Suzanne ^b   Graham, Michael M ^a   Buchwald, Dedra ^b,e  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d ROTMAN RESEARCH INSTITUTE   (Canada)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Brain, abnormalities, 13.899; Brain, perfusion; Brain, SPECT, 13.12162; Nervous system, abnormalities, 13.899; Twins

Indexed keywords

HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN DISEASE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MENTAL HEALTH; MONOZYGOTIC TWINS; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; TWIN DISCORDANCE;

EID: 0035000003     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.219.3.r01jn18766     Document Type: Article

References (49)

1. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study - International Chronic Fatigue Syndrome Study group. Ann Intern Med 1994; 121: 953-959.
2. Komaroff AL, Buchwald D. Symptoms and signs of chronic fatigue syndrome. Rev Infect Dis 1991; 13:S8-11.
3. Christodoulou C, DeLuca J, Lange G, et al. Relation between neuropsychological impairment and functional disability in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 1998; 64: 431-434.
4. DeLuca J, Johnson SK, Ellis SP, Natelson BH. Cognitive functioning is impaired in patients with chronic fatigue syndrome devoid of psychiatric disease. J Neurol Neurosurg Psychiatry 1997; 62:151-155.
5. Fiedler N, Kipen HM, DeLuca J, Kelly-McNeil K, Natelson B. A controlled comparison of multiple chemical sensitivities and chronic fatigue syndrome. Psychosom Med 1996; 58:38-49.
6. DeLuca J, Johnson SK, Beldowicz D, Natelson BH. Neuropsychological impairments in chronic fatigue syndrome, multiple sclerosis, and depression. J Neurol Neurosurg Psychiatry 1995; 58:38-43.
7. DeLuca J, Johnson SK, Natelson BH. Information processing efficiency in chronic fatigue syndrome and multiple sclerosis. Arch Neurol 1993; 50:301-304.
8. Abu-Judeh HH, Levine S, Kumar M, et al. Comparison of SPET brain perfusion and 18F-FDG brain metabolism in patients with chronic fatigue syndrome. Nucl Med Commun 1998; 19:1065-1071.
9. Ichise M, Salit IE, Abbey SE, et al. Assessment of regional cerebral perfusion by 99mTc-HMPAO SPECT in chronic fatigue syndrome. Nucl Med Commun 1992; 13: 767-772.
10. Schwartz RB, Garada BM, Komaroff AL, et al. Detection of intracranial abnormalities in patients with chronic fatigue syndrome: comparison of MR imaging and SPECT. AJR Am J Roentgenol 1994; 162: 935-941.
11. Schwartz RB, Komaroff AL, Garada BM, et al. SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression. AJR Am J Roentgenol 1994; 162:943-951.
12. Costa DC, Tannock C, Brostoff J. Brainstem perfusion is impaired in chronic fatigue syndrome. QJM 1995; 88:767-773.
13. Fischler B, D'Haenen H, Cluydts R, et al. Comparison of 99mTc HMPAO SPECT scan between chronic fatigue syndrome, major depression and healthy controls: an exploratory study of clinical correlates of regional cerebral blood flow. Neuropsychobiology 1996; 34:175-183.
14. Machale SM, Lawrie SM, Cavanagh JT, et al. Cerebral perfusion in chronic fatigue syndrome and depression. Br J Psychiatry 2000; 176:550-556.
15. Assessment of brain SPECT: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1996; 46:278-285.
16. Mayberg HS. Functional neuroimaging in CFS: applications and limitations. J Chron Fat Syn 1996; 1:9-20.
17. Lange G, Wang S, DeLuca J, Natelson BH. Neuroimaging in chronic fatigue syndrome. Am J Med 1998; 105:50S-53S.
18. Hrubec Z, Robinette CD. The study of human twins in medical research. N Engl J Med 1984; 310:435-441.
19. Buchwald DS, Herrell R, Ashton S, Belcourt M, Schmaling K, Goldberg J. The chronic fatigue twin registry: method of construction, composition and zygosity assignment. Twin Res 1999; 2:203-211.
20. Robins LN, Heizer JE. Diagnostic interview schedule (DIS): version III-A. St Louis, Mo: Washington University School of Medicine, 1985.
21. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, DC: American Psychiatric Association, 1987.
22. Torgersen S. The determination of twin zygosity by means of a mailed questionnaire. Acta Genet Med Gemellol (Roma) 1979; 28:225-236.
23. Eisen S, Neuman R, Goldberg J, Rice J, True W. Determining zygosity in the Vietnam Era Twin Registry: an approach using questionnaires. Clin Genet 1989; 35:423-432.
24. Keith L, Machin G. Zygosity testing: current status and evolving issues. J Reprod Med 1997; 42:699-707.
25. Fletcher JW, Woolf SH, Royal HD. Consensus development for producing diagnostic procedure guidelines: SPECT brain perfusion imaging with exametazime. J Nucl Med 1994; 35:2003-2010.
26. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978; NS-25: 638-643.
27. Slomka PJ, Reid BR, Hurwitz GA, Stephenson JA. Automated template-based quantification of brain SPECT. In: DeDeyn PP, Dierckx RA, Alavi A, Pickut BA, eds. A textbook of SPECT in neurology and psychiatry. London, England: Libbey, 1997; 507-512.
28. Zifko UA, Slomka PJ, Reid RH, Young GB, Remtulla H, Bolton CF. The cortical representation of somatosensory evoked potentials of the phrenic nerve. J Neurol Sci 1996; 139:197-202.
29. Radau P, Linke R, Slomka P, Tatsch K. Optimization of automated quantification of iodine-123-IBZM uptake in the striatum applied to Parkinsonism. J Nucl Med 2000; 41:220-227.
30. Deutsch G, Mountz JM, Katholi CR, Liu HG, Harrell LE. Regional stability of cerebral blood flow measured by repeated technetium-99m-HMPAO SPECT: implications for the study of state-dependent change. J Nucl Med 1997; 38:6-13.
31. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 1988; 54:1063-70.
32. Hedeker D, Gibbons RD. MIXREG: a computer program for mixed-effects regression analysis with autocorrelated errors. Comput Methods Programs Biomed 1996; 49:229-252.
33. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982; 38:963-974.
34. Waldemar G, Haselbach SG, Andersen AR, et al. 99mTc-d,1HMPAO and SPECT of the brain in normal aging. J Cereb Blood Flow Metab 1991; 11:508-521.
35. Buchwald D, Cheney PR, Peterson DL, et al. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med 1992; 116: 103-113.
36. Lange G, DeLuca J, Maldjian JA, Lee H, Tiersky LA, Natelson BH. Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome. J Neurol Sci 1999; 171:3-7.
37. Mayberg HS, Liotti M, Brannan SK, et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999; 156:675-682.
38. Schlaepfer TE, Strain EC, Greenberg BD, et al. Site of opioid action in the human brain: mu and kappa agonists' subjective and cerebral blood flow effects. Am J Psychiatry 1998; 155:470-473.
39. Roy-Byrne P, Fleishaker J, Arnett C, et al. Effects of acute and chronic alprazolam treatment on cerebral blood flow, memory, sedation and plasma catecholamines. Neuropsychopharmacology 1993; 8:161-169.
40. Bok BD, Scheffel U, Goldfarb HW, et al. Comparison of 99Tc-m complexes (NEP-DADT, ME-NEP-DADT and HMPAO) with 123IAMP for brain SPECT imaging in dogs. Nucl Med Comm 1987; 8:631-641.
41. Kinnunen E, Jarvinen P, Ketonen L, Sepponen R. Co-twin control study on cerebral manifestations of systemic lupus erythematosus. Acta Neurol Scand 1993; 88:422-426.
42. Uitdehaag BM, Polman CH, Valk J, Koetsier JC, Lucas CJ. Magnetic resonance imaging studies in multiple sclerosis twins. J Neurol Neurosurg Psychiatry 1989; 52: 1417-1419.
43. Berman KF, Torrey EF, Daniel DG, Weinberger DR. Regional cerebral blood flow in monozygotic twins discordant and concordant for schizophrenia. Arch Gen Psychiatry 1992; 49:927-934.
44. Weinberger DR, Berman KF, Suddath R, Torrey EF. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. Am J Psychiatry 1992; 149:890-897.
45. Clark CM, Klonoff H, Tyhurst JS, et al. Regional cerebral glucose metabolism in identical twins. Neuropsychologia 1988; 26:615-621.
46. Bartley AJ, Jones DW, Weinberger DR. Genetic variability of human brain size and cortical gyral patterns. Brain 1997; 120:257-269.
47. Tramo MJ, Loftus WC, Stukel TA, Green RL, Weaver JB, Gazzaniga MS. Brain size, head size, and intelligence quotient in monozygotic twins. Neurology 1998; 50: 1246-1252.
48. Deary IJ, Ebmeier KP, MacLeod KM, et al. PASAT performance and the pattern of uptake of 99mTc-exametazime in brain estimated with single photon emission tomography. Biol Psychol 1994; 38:1-18.
49. Peterson PK, Sirr SA, Grammith FC, et al. Effects of mild exercise on cytokines and cerebral blood flow in chronic fatigue syndrome patients. Clin Diagn Lab Immun 1994; 1:222-226.